Shareholder Information

Shares Issued

As at 27 November 2020, the number of shares in issue was 433,636,255.


Significant Shareholders

As at 27 November 2020

Shareholder Number Ordinary
Shares %
Craig Auringer 23,837,250 5.50
Samantha Bauer 17,082,201 3.94


Director Shareholdings

As at 27 November 2020

Director Number Ordinary
Shares %
Alexis Sandler 75,090,685 17.32
Dr Vladislav Sandler 41,544,677 9.58
Peter Redmond 5,596,270 1.29


Shares Not In Public Hands

Insofar as it is aware, as at 27 November 2020, 45.51% of the Company’s securities were not in public hands.


UK City Code On Takeovers And Mergers

The Company is subject to the provisions of the City Code on Takeovers and Mergers.


Shareholder Circulars

Annual and Half Year Reports, together with historical general meeting notices, blank proxy voting forms, and other shareholder circulars, may be found here: Annual and Half Year Reports.

Most recent shareholder circular:

8 December 2020 Notice of General Meeting to be held on 6 January 2021


Other Exchanges And Trading Platforms

Hemogenyx Pharmaceuticals plc has not applied or agreed to have any of it securities admitted or traded on any other exchanges or trading platforms.